Growth and Innovation in Peru's In-Vitro Diagnostics Market

The Peru In-Vitro Diagnostics (IVD) Market was valued at USD 135.0 million in 2023 and is projected to reach USD 163.3 million by 2030, growing at a compound annual growth rate (CAGR) of 2.4% from 2024 to 2030. IVD encompasses laboratory-based tests performed on biological samples such as blood, tissues, and bodily fluids to diagnose diseases, monitor therapies, and evaluate overall health. The market growth in Peru is driven by rising healthcare investments, an increasing burden of chronic diseases including cancer, and the adoption of advanced diagnostic technologies such as immunoassays, molecular diagnostics, hematology, and clinical chemistry. However, high costs associated with research, development, and regulatory approvals continue to restrain market expansion. The emergence of point-of-care testing (POCT) presents significant opportunities by enabling rapid, accurate diagnostics and facilitating patient-centered care. This manuscript provides a detailed analysis of market drivers, restraints, segmentation, and the competitive landscape of the Peru IVD market.